Javascript must be enabled to continue!
Effect of a critical coronary stenosis on myocardial neutrophil accumulation during ischemia and early reperfusion in dogs.
View through CrossRef
In many experimental models of ischemia and reperfusion, reperfusion is performed abruptly, allowing full reactive hyperemia to occur. In the clinical setting, however, reperfusion after thrombolysis is often limited by residual stenosis. Some experimental models attempt to mimic this situation with a "critical stenosis" (defined as a coronary constriction sufficient to abolish reactive hyperemia without altering baseline flow). The purpose of this study was to determine whether preventing reactive hyperemia during the initial phase of reperfusion would modify the transmural distribution of myocardial blood flow or the myocardial accumulation of polymorphonuclear leukocytes (PMNs). The left circumflex artery was occluded for 90 minutes and then reperfused for 60 minutes in anesthetized, open-chest dogs. Autologous PMNs were isolated, labeled with 111In, and reinjected 1 hour before coronary occlusion. 125I-labeled albumin was injected simultaneously to correct for 111In associated with plasma proteins and to permit calculation of the number of PMNs in the inner, middle, and outer thirds of nonischemic and ischemic-reperfused tissue. The presence of a critical stenosis abolished reactive hyperemia during the first 5 minutes of reperfusion, but did not substantially affect blood flow measured after 55 minutes of reperfusion. In both groups, there was a significant accumulation of PMNs in all layers of the ischemic-reperfused bed compared with the nonischemic bed, and the magnitude of this PMN accumulation was not altered by the presence of a critical stenosis. Moreover, infarct size, estimated by triphenyl tetrazolium chloride (TTC) loss after 60 minutes of reperfusion, was not affected by the presence of a critical stenosis. Thus, the presence of a critical stenosis abolished the hyperemic blood flow after reperfusion but did not influence the early PMN response to ischemia and reperfusion or the early loss of TTC staining.
Ovid Technologies (Wolters Kluwer Health)
Title: Effect of a critical coronary stenosis on myocardial neutrophil accumulation during ischemia and early reperfusion in dogs.
Description:
In many experimental models of ischemia and reperfusion, reperfusion is performed abruptly, allowing full reactive hyperemia to occur.
In the clinical setting, however, reperfusion after thrombolysis is often limited by residual stenosis.
Some experimental models attempt to mimic this situation with a "critical stenosis" (defined as a coronary constriction sufficient to abolish reactive hyperemia without altering baseline flow).
The purpose of this study was to determine whether preventing reactive hyperemia during the initial phase of reperfusion would modify the transmural distribution of myocardial blood flow or the myocardial accumulation of polymorphonuclear leukocytes (PMNs).
The left circumflex artery was occluded for 90 minutes and then reperfused for 60 minutes in anesthetized, open-chest dogs.
Autologous PMNs were isolated, labeled with 111In, and reinjected 1 hour before coronary occlusion.
125I-labeled albumin was injected simultaneously to correct for 111In associated with plasma proteins and to permit calculation of the number of PMNs in the inner, middle, and outer thirds of nonischemic and ischemic-reperfused tissue.
The presence of a critical stenosis abolished reactive hyperemia during the first 5 minutes of reperfusion, but did not substantially affect blood flow measured after 55 minutes of reperfusion.
In both groups, there was a significant accumulation of PMNs in all layers of the ischemic-reperfused bed compared with the nonischemic bed, and the magnitude of this PMN accumulation was not altered by the presence of a critical stenosis.
Moreover, infarct size, estimated by triphenyl tetrazolium chloride (TTC) loss after 60 minutes of reperfusion, was not affected by the presence of a critical stenosis.
Thus, the presence of a critical stenosis abolished the hyperemic blood flow after reperfusion but did not influence the early PMN response to ischemia and reperfusion or the early loss of TTC staining.
Related Results
The combination of Pitavastain and ischemic postconditioning attenuates myocardial ischemic/reperfusion injury in impaired glucose tolerance rat in vivo
The combination of Pitavastain and ischemic postconditioning attenuates myocardial ischemic/reperfusion injury in impaired glucose tolerance rat in vivo
Background and Objectives
Myocardial ischemia-reperfusion injury (MIRI) can be alleviated by ischemia post-conditioning (IPC) and/or statin post-conditioning (SPC...
Critical Arterial Stenosis Revisited
Critical Arterial Stenosis Revisited
Abstract
Introduction
Stenosis of an organ/tissue primary artery can produce ischemia or only reduce blood flow reserve. Despit...
Assessing the Appropriateness and Effectiveness of Coronary CT Angiography in COVID-19 Patients with Chest Pain
Assessing the Appropriateness and Effectiveness of Coronary CT Angiography in COVID-19 Patients with Chest Pain
Coronary CT Angiography (CCTA) is well established for Chest Pain (CP) evaluation to assess coronary artery stenosis. However, the appropriateness of CCTA for COVID-19 patients wit...
Diagnostic efficacy of CCTA and CT-FFR based on risk factors for myocardial ischemia
Diagnostic efficacy of CCTA and CT-FFR based on risk factors for myocardial ischemia
Abstract
Background
Coronary artery coronary computed tomography angiography (CCTA) can observe the degree of coronary artery stenosis and fractiona...
Salvia miltiorrhiza injection ameliorates myocardial ischemia-reperfusion injury via downregulation of PECAM-1
Salvia miltiorrhiza injection ameliorates myocardial ischemia-reperfusion injury via downregulation of PECAM-1
Purpose: To investigate the effect of Salvia miltiorrhiza injection on myocardial ischemia-reperfusion injury and PECAM-1 related pathways.
Method: Male Wistar rats were used...
e0543 Clinical and coronary angiography characteristics between young (<45) and old (>60) patients with coronary artery disease
e0543 Clinical and coronary angiography characteristics between young (<45) and old (>60) patients with coronary artery disease
Objective
To study the clinical Clinical and coronary angiography characteristics between young (≤45) and old (>60) patients with coronary artery disease.
...
e0425 Clinical and coronary angiography characteristics between young (≤45) and old (>60) patients with coronary artery disease
e0425 Clinical and coronary angiography characteristics between young (≤45) and old (>60) patients with coronary artery disease
Objective
To study the clinical Clinical and coronary angiography characteristics between young (≤45) and old (>60) patients with coronary artery disease.
...
Autoantibodies against β3-adrenoceptor reduce the susceptibility to myocardial ischemic/reperfusion injury of heart failure rats
Autoantibodies against β3-adrenoceptor reduce the susceptibility to myocardial ischemic/reperfusion injury of heart failure rats
Objective
Choosing chronic heart failure rats as starting point, to observe whether Autoantibodies against β3-adrenoceptor (β3AA) can reduce the susceptibility to...

